Twist Biosciences Files for IPO
FLG Partner’s, Ken Chow, was Interim CFO at Twist Biosciences in late 2016 to May 2017 when the company filed their S-1 for their upcoming IPO which was announced today. Press release from Genome-Web follows: NEW YORK (GenomeWeb) – Synthetic biology firm Twist Biosciences filed for an $86.3 million initial…Read More
Read MoreCoinbase: A CFO Moves from Corporate Finance to Crypto Currency
By Kevin Manne – University of Buffalo, School of Management Over the course of his career, Tim Laehy, FLG Partner and University of Buffalo graduate (BS ’84, MBA ’85), has served in the Chief Financial Officer role at eight different companies, raising more than $3 billion in capital through three…Read More
Read MoreBuildDirect Installs New Executive Team
By Sean Silcoff – The Globe and Mail Three months after emerging from credit protection, Vancouver’s BuildDirect.com Technologies Inc. unveiled a new management team on Tuesday that is dominated by former Amazon.com Inc. executives. Chief technology officer Mukund Mohan, chief revenue officer Ken Stanick and chief merchandising officer Godwin Pavamani, all former…Read More
Read MoreFive Prime Therapeutics, Inc. Engages FLG Partners
April 13, 2018 – Five Prime Therapeutics, Inc. (NASDAQ: FPRX) announced today that FLG partner Linda Rubinstein has been engaged as interim Chief Financial Officer. Company Form 8-K.
Read MoreDigiSight Technologies Inc. Form Collaboration With American Academy of Opthalmology
The American Academy of Ophthalmology and FLG client, DigiSight Technologies, Inc. have announced a collaboration agreement to operate the world’s largest database of ophthalmic clinical information. As part of the agreement, the Academy is licensing commercial application of its IRIS® Registry (Intelligent Research in Sight) to DigiSight. FLG’s Jonathan Wolter has been CFO…Read More
Read More
Recent News
